All treatment programs focused on disease prevention, harm reduction or the treatment or prevention of alcoholism, substance abuse or chemical dependency that are officially recognized by a federal, state or local government agency shall automatically be approved by the board. Upon submission of a complete application for a treatment program that fulfills the requirements listed below, the board shall issue a treatment program approval.
A. the treatment program approval application fee specified in 16.2.10 NMAC;B. complete application for treatment program approval in English that shall include the applicant's name, address, phone number, fax number and email address, if available, and: (1) affidavit that the treatment program is for disease prevention, harm reduction or the treatment or prevention of alcoholism, substance abuse or chemical dependency;(2) whether the facility is at a fixed address or is mobile;(3) the name of the director of the program;(4) the number and qualifications of the treatment staff; and(5) the name of the auricular detoxification supervisor and the certified auricular detoxification specialist, if known; andC. an affidavit as provided on the treatment program approval application form stating that the facility has access to a toilet and a sink; andD. an affidavit as provided on the treatment program approval application form stating that the applicant understands that: (1) the treatment program must notify the board within 10 days if the program's address or phone number changes; and(2) the board may refuse to issue, or may suspend, or revoke any treatment program approval in accordance with the Uniform Licensing Act, 61-1-1 to 61-1-31 NMSA 1978, for reasons authorized in Section 61-14A-17 NMSA 1978 of the act and clarified in 16.2.12 NMAC.N.M. Admin. Code § 16.2.16.28
16.2.16.28 NMAC - N, 02-15-05; A, 12-26-08; A, 03-02-14, Adopted by New Mexico Register, Volume XXXIII, Issue 02, January 26, 2022, eff. 2/11/2022, Amended by New Mexico Register, Volume XXXV, Issue 20, October 22, 2024, eff. 10/22/2024